Myriad Genetics (NASDAQ:MYGN) Sets New 1-Year Low After Earnings MissMarket Beat·1 day ago, 07:40 PMMYGN-46.74%
MYRIAD GENETICS INC 2026: Revenue $190.7M, EPS ($0.46) — 10-Q SummaryTradingView·1 day ago, 07:11 AMMYGN-46.74%
Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Sessionbenzinga_article·1 day ago, 07:03 AMSYK-6.42%MYGN-46.74%
Myriad Genetics Stock Drops Sharply After Hours: What Investors Need to Knowbenzinga_article·1 day ago, 12:48 AMMYGN-46.74%
Myriad Genetics: Q2 Miss, Guidance Cut Lead to Lower $4 Price Target and Maintained Hold RatingTip Ranks·2 days ago, 09:55 PMMYGN-46.74%
MYGN: Q2 revenue declined 11% year-over-year, prompting lower 2026 guidance and operational changesQuartr·2 days ago, 05:12 PMMYGN-46.74%
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga_article·2 days ago, 04:05 PMNUWE-60.90%QURE+3.41%
Myriad Genetics Q2 FY26 operating loss narrows to $38.9 million; revenue drops 11% to $190.7 millionPUBT·2 days ago, 03:32 PMMYGN-46.74%
Myriad Genetic | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 190.7 MEarnings Watch·2 days ago, 03:19 PMMYGN-46.74%
Myriad Genetics rebuilt its AI platform after costs ballooned. Now, it can process documents in seconds.businessinsider·Jul 27 at 04:17 PMMYGN-46.74%
Bank of America Securities Keeps Their Sell Rating on Myriad Genetics (MYGN)Tip Ranks·Jul 13 at 05:16 AMMYGN-46.74%RANK+1.65%
